Abstract:Prions are proteins that can adopt at least 2 distinct conformations (structural states), being one of them soluble, either natively folded or intrinsically disordered, and the other an aggregated fibrillar structure, termed amyloid, made of stacked ß-strands contributed by the individual protein molecules [1]. Amyloids propagate their conformation to soluble protein molecules of their same kind by contact, capturing them as new building blocks of their elongating fibers. Conformational variants (i.e., alternative 3D folds for the same protein sequence) of an amyloid assembly can be propagated as distinct prion strains vertically with cell division, from mother to daughter cells, for many generations constituting a case for cytoplasmatic, non-mendelian epigenetic inheritance [1]. After the pioneering discovery of the mammalian prion protein PrP [2], the whole field was boosted by findings in the yeast Saccharomyces cerevisiae , in which several transcriptional and translational factors (such as Sup35 and Ure2) were shown to aggregate as amyloids, resulting in loss-of-function phenotypes ([ PSI + ] and [ URE3 ], respectively) [3,4]. Alternative strains of yeast prions were horizontally transmissible between cells while mating through cytoduction (i.e., cytoplasmatic mixing) [5]. In yeast, depending on the protein, its amyloid state either elicits a functionally adaptive phenotypic change or becomes cytotoxic and deleterious [6,7]. Horizontal transmission as an infectious agent has been recently described also for amyloid proteins involved in human neurodegenerative diseases such α-synuclein, Tau, the ß-amyloid peptides, and TDP-43, self-propagating as prion-like proteins (or prionoids) between cells within different areas of the central nervous system [8]. In bacteria, as exemplified by the Escherichia coli biofilm scaffolding protein CsgA, some extracellular secreted proteins rely on a complex, dedicated protein machinery for their regulated assembly as functional amyloids, with defined fibrillar structures and physiological roles [9]. These are distinct to prions, in which the soluble monomers are functional while the amyloid fibrils that they assemble, usually polymorphic, lose that function [8]. Mining in prokaryotic proteomes identified many proteins with potential prion forming domains (PrDs), typically intrinsically disordered (IDPs) and with overall polar residue composition, similar to those in yeast prions [10,11]. However, so far detailed experimental characterization of bacterial prions is restricted to individual domains in just 3 proteins adopting an amyloid state (Fig 1).

Cryo-EM structure of a human prion fibril with a hydrophobic, protease-resistant core

The Positively Charged Cluster in the N-terminal Disordered Region may Affect Prion Protein Misfolding: Cryo-EM Structure of Hamster PrP(23–144) Fibrils

Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core

Unfolding Mechanism and Fibril Formation Propensity of Human Prion Protein in the Presence of Molecular Crowding Agents

Loss of Residues 119-136, Including the First β-strand of Human Prion Protein, Generates an Aggregation-competent Partially "Open" Form

On the Fibril Elongation Mechanism of the Prion Protein Fragment PrP106-126

Cryo-EM structure of alpha-synuclein fibrils amplified by PMCA from PD and MSA patient brains

Structural and dynamical determinants of a β-sheet-enriched intermediate involved in amyloid fibrillar assembly of human prion protein

Cryo-EM structure of a natural prion: chronic wasting disease fibrils from deer

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

Structural and Dynamic Properties of the Human Prion Protein.

Genetic prion disease–related mutation E196K displays a novel amyloid fibril structure revealed by cryo-EM

High-Resolution Cryo-EM Structure Determination of α-Synuclein – A Prototypical Amyloid Fibril

Optimal atomic-resolution structures of prion AGAAAAGA amyloid fibrils

Cryo-EM structure of an amyloid fibril formed by full-length human SOD1 reveals its conformational conversion

The emergence of bacterial prions

The allure and pitfalls of the prion-like aggregation in neurodegeneration

A strategy on prion AGAAAAGA amyloid fibril molecular modelling

Helices 2 and 3 are the initiation sites in the PrPc -> PrPsc transition

Interaction Between 14-3-3β and PrP Influences the Dimerization of 14-3-3 and Fibrillization of PrP106-126.

The Folding Mechanism And Key Metastable State Identification Of The Prp127-147 Monomer Studied By Molecular Dynamics Simulations And Markov State Model Analysis